Literature DB >> 16110758

Rational design of new electrodes for electrochemotherapy.

E P Spugnini1, G Citro, A Porrello.   

Abstract

Electrochemotherapy associates the local delivery of anticancer drugs with the administration of permeabilizing electric pulses that support the antiblastic action. The basic instrumentation for this therapy is constituted by a pulse generator and various specific electrodes. While many efforts have been profuse by researchers in this field to obtain the standardization of the pulse generating equipment over the past 15 years, the delivery apparatus still needs refinements in order to reach most of the body districts, to control the homogeneity and stability of the electric fields and to further reduce morbidity. With the aim to develop innovative electrodes able to satisfy, at least partially, these requirements, extensive studies on pet patients with spontaneous neoplasms have been conducted, leading to the manufacturing of several different prototypes. In this paper we discuss the rationale of 11 different electrodes, briefly summarize the results obtained and their experimental validation, also presenting five paradigmatic clinical cases. In particular, it is shown that the caliper electrodes are more suited for the treatment of cutaneous and subcutaneous lesions, while the needle arrays are more efficacious in intraoperative settings. Furthermore, relevant peculiarities of unipolar electrodes are examined with a particular focus on the irregular current paths that they produce and on the potentialities of this feature. Remarkably, the decrease of the steric encumbrance turned out to be a stronger factor in electrode design than the containment of the total number of electric fields covered in serial ECT sessions. In the conclusions, perspectives and new challenges of electrode design for electrochemotherapy are illustrated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16110758

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  7 in total

1.  Modulation of activity of known cytotoxic ruthenium(III) compound (KP418) with hampered transmembrane transport in electrochemotherapy in vitro and in vivo.

Authors:  Rosana Hudej; Damijan Miklavcic; Maja Cemazar; Vesna Todorovic; Gregor Sersa; Alberta Bergamo; Gianni Sava; Anze Martincic; Janez Scancar; Bernhard K Keppler; Iztok Turel
Journal:  J Membr Biol       Date:  2014-06-24       Impact factor: 1.843

2.  Electrodelivery of drugs into cancer cells in the presence of poloxamer 188.

Authors:  Iana Tsoneva; Iordan Iordanov; Annette J Berger; Toma Tomov; Biliana Nikolova; Nikola Mudrov; Martin R Berger
Journal:  J Biomed Biotechnol       Date:  2010-07-25

3.  Electroporation increases antitumoral efficacy of the bcl-2 antisense G3139 and chemotherapy in a human melanoma xenograft.

Authors:  Enrico P Spugnini; Annamaria Biroccio; Roberta De Mori; Marco Scarsella; Carmen D'Angelo; Alfonso Baldi; Carlo Leonetti
Journal:  J Transl Med       Date:  2011-07-28       Impact factor: 5.531

Review 4.  Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans.

Authors:  Enrico P Spugnini; Gennaro Citro; Alfonso Baldi
Journal:  J Exp Clin Cancer Res       Date:  2009-08-14

5.  Biphasic pulses enhance bleomycin efficacy in a spontaneous canine genital tumor model of chemoresistance: Sticker sarcoma.

Authors:  Enrico P Spugnini; Ivan Dotsinsky; Nikolay Mudrov; Gennaro Citro; Alfredo D'Avino; Alfonso Baldi
Journal:  J Exp Clin Cancer Res       Date:  2008-11-03

6.  Patterns of tumor response in canine and feline cancer patients treated with electrochemotherapy: preclinical data for the standardization of this treatment in pets and humans.

Authors:  Enrico P Spugnini; Feliciano Baldi; Pasquale Mellone; Florinda Feroce; Alfredo D'Avino; Francesco Bonetto; Bruno Vincenzi; Gennaro Citro; Alfonso Baldi
Journal:  J Transl Med       Date:  2007-10-02       Impact factor: 5.531

7.  Delivery of RNAi-Based Oligonucleotides by Electropermeabilization.

Authors:  Sophie Chabot; Sandrine Pelofy; Justin Teissié; Muriel Golzio
Journal:  Pharmaceuticals (Basel)       Date:  2013-04-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.